| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.3M | +122.9% |
| SG&A Expense | $1.6M | +0.9% |
| Operating Income | -$7.8M | -79.7% |
| Pre-tax Income | -$9.0M | +70.4% |
| Net Income | -$9.0M | +70.4% |
| EPS (Basic) | -$0.20 | +77.5% |
| EPS (Diluted) | -$0.20 | +77.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | +11.3% |
| Current Assets | $5.2M | +3.4% |
| Total Assets | $5.2M | +3.4% |
| Current Liabilities | $605K | +109.3% |
| Total Liabilities | $605K | +109.3% |
| Stockholders' Equity | $4.6M | -3.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | -53.3% |
| Financing Cash Flow | $4.5M | -37.9% |